TENNIS ANTI-DOPING PROGRAMME
Decision In The Case Of Dimitar Kutrovsky
Dimitar Kutrovsky Decision
by Press Release|
The International Tennis Federation announced today that Dimitar Kutrovsky has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s sample).
Mr Kutrovsky, a 24-year-old tennis player from Bulgaria, provided a sample on 14 February 2012 at the SAP Open held in San Jose, United States. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain methylhexaneamine, a stimulant. Methylhexaneamine is a Prohibited Substance under section S6 of the 2012 WADA List of Prohibited Substances and Prohibited Methods, and is therefore also prohibited under the Tennis Anti-Doping Programme (TADP). Mr Kutrovsky was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.
Mr Kutrovsky asserted that the methylhexaneamine, for which he did not hold a valid therapeutic use exemption, had got into his system through his ingestion of the supplement Jack3d. He denied any intent to enhance his performance as a result of taking the Jack3d.
The ITF did not dispute Mr Kutrovsky’s account of the circumstances surrounding his ingestion of methylhexaneamine, but asserted that he had not demonstrated to the required standard that he (a) did not intend to enhance his performance, and so failed to meet the requirements to satisfy article 10.4 of the TADP (Elimination or Reduction of the Period of Ineligibility for Specified Substance under Specified Circumstances), and (b) bore No Significant Fault or Negligence.
The tribunal concurred, and therefore confirmed Mr Kutrovsky’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme, and determined that he should be suspended from participation for a period of two years, back-dated to commence from 14 February 2012 and so ending at midnight on 13 February 2014. The tribunal also determined that Mr Kutrovsky’s results at the 2012 SAP Open and Brownsville Futures events should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at those events.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at tournaments sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that a Doping Offence has been committed, sanctions are imposed in accordance with the requirements of the World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.